CDC Interim Guidance for COVID-19 Booster Vaccinations

Published: 09/28/2021

  • Centers for Disease Control and Prevention
Relevant To:
  • All Healthcare Organizations

Last week the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series.  Today’s StayAlert! Notice reviews the U.S. Centers for Disease Control and Prevention’s (CDC) interim guidance reflecting the FDA’s authorization. 

The CDC recommends a Pfizer-BioNTech COVID-19 booster shot to help increase their pro

Sign Up for Free Trial